Skip to content

Abstinence-Linked Money Management Multisite

Abstinence-Linked Money Management Multisite

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01327586
Enrollment
108
Registered
2011-04-01
Start date
2009-12-31
Completion date
2014-01-31
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dual Diagnosis, Cocaine Abuse, Cocaine Dependence, Polysubstance Abuse

Keywords

disability, substance abuse, cocaine abuse, dual diagnosis, representative payee, HIV risk reduction

Brief summary

Randomized clinical trial comparing a money management-based intervention involving storage and management of client funds, substance abuse counseling, and risk reduction counseling to individualized drug counseling.

Interventions

BEHAVIORALATM

Weekly counseling focused on improving money management, abstaining from cocaine,and minimizing unprotected sex

Standard individualized drug counseling, modified from that described by Woody and colleagues

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Enrolled in ambulatory psychiatric treatment at one of the participating clinics * Receives SSI or SSDI payments * Able to provide written informed consent * Cocaine use within the last 60 days as evidenced by either a positive toxicology screen or self-reports

Exclusion criteria

* Has a conservator of person * A history of violence towards clinical providers or predatory violence * Suicidal plans or intent; homicidal plans or intent. Suicidal or homicidal ideation will not be

Design outcomes

Primary

MeasureTime frame
Proportion of Urine toxicology tests without cocaineMonth 0,1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12

Secondary

MeasureTime frameDescription
Unprotected sexual encountersMonth 0, 1,2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12ACASI-measured

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026